Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, December 18, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Medtech
Imbed Biosciences Receives FDA 510(k) Clearance for Microlyte® Ag/Lidocaine
Life Sciences Times
-
October 31, 2024
0
Medtech
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
Life Sciences Times
-
October 31, 2024
0
People on the Move
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
Life Sciences Times
-
October 31, 2024
0
People on the Move
Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer
Life Sciences Times
-
October 31, 2024
0
Medtech
GoodRx Unveils New E-commerce Platform, Launches with Opill®
Life Sciences Times
-
October 31, 2024
0
People on the Move
Vernal Biosciences Appoints Jim Petrilla as CEO & Board Director
Life Sciences Times
-
October 31, 2024
0
People on the Move
Former Deputy Commissioner of New York State Department of Health Joins Sheppard Mullin
Life Sciences Times
-
October 30, 2024
0
Medtech
DermaSensor in TIME’s List of the Best Inventions of 2024
Life Sciences Times
-
October 30, 2024
0
People on the Move
Orthobond Appoints George Landau as New EVP, Business Development and Commercialization
Life Sciences Times
-
October 30, 2024
0
Pharma
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
Life Sciences Times
-
October 30, 2024
0
1
...
9
10
11
...
572
Page 10 of 572
Most Popular
VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
December 16, 2024
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
December 16, 2024
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
December 12, 2024
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
December 12, 2024
Load more
Recent Comments
Recent Comments